Company
Current
Narcan nasal spray maker Emergent BioSolutions has a new CEO
Joseph C. Papa Joins Water Street Healthcare Partners
Bausch Health Continuing Process Toward Separating Bausch + Lomb - Eyewire+
Bausch + Lomb CEO to step down
BAUSCH + LOMB CORPORATION LAUNCHES AS A PUBLICLY TRADED COMPANY
Bausch Health Announces Thomas J. Appio As Chief Executive Officer
Bausch + Lomb announces XIPERE commercial launch in US | Eye Care Network - Modern Retina
Bausch Health Announces Vyzulta Now Approved in Seven Countries; Expanded Coverage in Canada - Eyewire+
Bausch Health CEO: Big Pharma will survive US drug regulations
Bausch Health Announces Resolution Of XIFAXAN® Intellectual Property Litigation
Bausch Health Companies Inc. Completes Name Change
Valeant to Change its Name to Bausch Health Companies, Reports Loss in First Quarter